STRATEC Biomedical AG 

10.09.2012 15:10

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

Allianz Global Investors Europe GmbH, Frankfurt/Main, Germany, has notified us pursuant to section 21 (1) sentence 1 of the German Securities Trading Act (WpHG) on September 7, 2012 as follows:

'We hereby give notice pursuant to section 21 (1) sentence 1 of the German Securities Trading Act (WpHG) that our voting rights in STRATEC Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld, exceeded the threshold of 3% on July 5, 2012 and on that day amount to 3.05% of all voting rights of the Company (this reflects 356,568 of all 11,703,045 voting rights).
With respect to our voting rights, 0.24% of all voting rights (this reflects 27,598 of all 11,703,045 voting rights) are attributed to us pursuant to section 22 (1) sentence 1 number 6 of the German Securities Trading Act (WpHG).'



10.09.2012 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  

---